microdosing bpc 157 Chromatographic and mass spectrometry behavior of BPC-157 and labeled Multifunctionality and Possible Medical Application

& Bonifati, V

Peptide therapy uses targeted amino-acid sequences that mimic or influence natural hormones and growth factors in the body, delivered most often by subcutaneous injections, occasionally by oral or other routes depending on the molecule

With many patients on dosages between 300 and 600 mg per day, a dose change of about 50mg every 2-4 weeks may be appropriate for patients

Liver function tests to evaluate hepatic contribution to clotting factor production

While it has been studied for decades, it has never advanced into full pharmaceutical approval

2 This subcutaneous chemical irritant activates peripheral nerves, leading to the activation of dorsal horn neurons